Amazing (and bonkers!) Go @LesleyLesleys ! 🥳🙌
1/26 Let’s get this party started! Getting my 26 hour danceathon and costumeathon underway with a ❤️NHS outfit #clapforcarers #clapforkeyworkers @NHS
Huge appreciation for everything being done to help us fight coronavirus 👏
uk.virginmoneygiving.com/Les…
Ilaria Mirabile retweeted
Closing date 30 March - Project Manager role in the the wonderful (but I’m biased!) #LivingWithAndBeyondCancer team @NHSEngland - Do apply! jobs.nhs.uk/xi/vacancy/91600…
@alicesimon @JbsNoor @nee5a @1ila
Ilaria Mirabile retweeted
Ilaria Mirabile @1ila is a group leader at the @NHSEngland. Ilaria is working on projects to improve the collaboration between sectors for a better healthcare bit.ly/2UmUwmQ #FLIER #FutureLeaders
Very happy to be part of this. Thought provoking conversations and stimulating colleagues. Looking forward to the journey! #FLIER @acmedsci @AMS_Careers
Today, we are delighted to announce the second cohort of our #FLIER scheme for future leaders - see the full list of awardees on our website ow.ly/rr8n50ycPde #ECRchat
Ilaria Mirabile retweeted
Job opportunity! Recruiting a Patient & Public Engagement Manager to lead #PPE for the national #NHS #Cancer Programme. Join our team to ensure NHS cancer services are shaped by the people that use them. jobs.nhs.uk/xi/vacancy/?vac_… Closes 17 Feb. #PatientVoice #PatientExperience
Ilaria Mirabile retweeted
Coordinated by ECMC, a new report outlining recommendations for the effective delivery of Complex Innovative Design (CID) cancer trials in the UK and Europe for the first time has now been published in @BrJCancer.
Read the full recommendations: doi.org/10.1038/s41416-019-0…
Come join us at the Silent theatre 1 for @alicesimon ‘s talk on our world leading Quality of Life metric #canceralliances @NHSEngland @NCRI_partners #ncri2019 @LesleyLesleys
Ilaria Mirabile retweeted
Panel discussion on the UK’s readiness for Complex Innovative Design trials @ICRTweets @UniofOxford @ICPVtweets @NICEcomms @ABPI_UK @MHRAgovuk #ANM19
Ilaria Mirabile retweeted
Great turnout for the ECMC annual network meeting. Discussion started on ‘is the UK ready to run complex innovative trial designs?’. Answer of course is yes! But what are the hurdles?
@ECMC_UK @sarah_blagden
#ANM19
A fire alarm can’t stop them!@ECMC_UK leads discussing opportunities for #earlyphasetrials in the UK in the sun #ANM19
Great to be here representing the @ECMC_UK network
The #FORUM workshop in #adaptivetrials just started with Prof Deborah Ashby welcome and introduction @acmedsci @MHRAgovuk @The_MRC @NICEcomms
Ilaria Mirabile retweeted
We hope you have had a fantastic time at #PharmaIntegrates, we’ve loved hearing important industry insights shared, debated and created 🎉 If you want to relive today's panel discussions and workshops then be sure to check out our highlights: xitter.cf/i/moments/106240148505…
Matt Bonam @AstraZeneca ‘ you can have all the #innovation you like, but no one using it if you are not able to show real (#patient) benefit ‘ @LSIntegrates #PharmaIntegrates #pharma #biotech #healthcare
Martino Picardo on pre-competitive parternships to bring new #medicine to market faster: the golden triangle is people, money, infrastructure #PharmaIntegrates @LSIntegrates
#PharmaIntegrates @LSIntegrates @ScripMikeWard on how to support long-term strategy for #healthcare innovation in the UK: the is good at #science . The best thing the government can do is to invest in scientists and let them innovate
#PharmaIntegrates @LSIntegrates C.Heinemann: #transformation and #innovation aren’t ‘one-time’ event in #pharma. Geographical, scientific and structural transformations all happening at the same time and hard to predict outcomes and interactions
Ilaria Mirabile retweeted
Early results from a ground breaking study of tumour evolution identifies genetic drivers in NSCLC. Unique translational research aims to establish models of tumour progression @CR_UK @CRUKresearch #ESMO18 #ESMO2018 esmo.org/Oncology-News/TRACE…